PLA2G7 and colorectal cancer: In a first cohort of patients with pancreatic and colorectal cancer (Table1), plasma PLA2G7 protein levels were significantly higher in patients who experienced weight loss within the past 3 months (i.e. weight‐losing) compared with healthy individuals (Figures4A and 4B).